Lee TM, Chen CC, Chang NC. Granulocyte colony-stimulating factor increases sympathetic reinnervation and the arrhythmogenic response to programmed electrical stimulation after myocardial infarction in rats.
GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) is known to mobilize progenitor cells from the bone marrow and resident cardiac progenitor cells (4) . G-CSF mobilized progenitor cells are not only capable of tissue differentiation but are also likely to regenerate the myocardium, resulting in improved cardiac function in animal and human studies (40, 41) . Despite promising results of G-CSF therapy, this treatment is potentially hazardous because of the cytokine's multisystemic effects. Late-onset toxicity has been a concern as a result of nonessential cells, such as neural stem cells, incorporating into the regenerating myocardium, resulting in the generation of noncardiac tissues and life-threatening arrhythmias. A recent study (19) showed fatal ventricular fibrillation after G-CSF administration, and G-CSF can induce neuronal differentiation (35) . Coculture of mesenchymal stem cells and neonatal rat ventricular myocytes produced an arrhythmogenic substrate that facilitated reentry (7). Pak et al. (33) demonstrated that mesenchymal stem cell injection to the swine myocardium induces increased sympathetic nerve sprouting throughout the ventricles. In contrast, others (2, 25) have recently shown that G-CSF administration 1-7 days before the induction of myocardial infarction (MI) attenuated fatal ventricular arrhythmias. However, the cytokine treatment was started before MI in these studies. Because treatment before acute MI is a virtual impossibility in most clinical situations, there has been a great deal of interest in understanding the effects of G-CSF and using it as an adjunctive treatment (starting treatment after MI) of arrhythmias.
Nerve growth factor (NGF) is a trophic factor that is critical for the differentiation, survival, and synaptic activity of the peripheral sympathetic and sensory nervous systems (39) . In ischemic hearts, an increase in cardiac NGF leads to the regeneration of sympathetic nerves (5, 24) . Expression of cardiac NGF correlates with the density of sympathetic innervation in the heart (36) , and the amount of NGF can affect sympathetic nerve survival and synaptic transmission between neurons and cardiac myocytes (30) . These results demonstrate the importance of NGF in the regulation of sympathetic innervation.
Increased sympathetic nerve density after myocardial injury has been shown to be highly associated with the occurrence of lethal arrhythmias and sudden cardiac death in humans (6) . During the chronic stage of MI, a regional increase in sympathetic nerves has been commonly observed (43) . Nerve fiber innervation after myocardial damage may have occurred via the mobilization of neural stem cells. During embryogenesis, the intermediate filament protein nestin (a marker of adult neural stem cells) is expressed in migrating and proliferating cells, whereas during differentiation, nestin is downregulated (44) . However, after injury to muscular or neuronal tissue, nestin expression is transiently reinduced (44) . Based on the postulated role of neural stem cell recruitment to damaged tissue, we assessed 1) whether the long-term effect of G-CSF adjunctive therapy after infarction can modulate sympathetic reinnervation in a rat MI model and 2) the role of nestinexpressing neural stem cells and NGF expression in nerve sprouting. Functional and immunohistochemical analyses were performed on days 5 and 56 after MI, time points reflecting the early and late phase of post-MI remodeling in rats.
METHODS

Animals.
Male Wistar rats were subjected to ligation of the anterior descending artery as previously described (28) , resulting in infarction of the left ventricular (LV) free wall. Animals were anesthetized with an intraperitoneal injection of ketamine (70 mg/kg). Twenty-four hours after MI, rats were randomized into groups to receive saline (MI/C group; subcutaneous administration of saline daily for 5 days) or G-CSF (MI/G group; 50 g/kg, subcutaneous administration, Filgrastim, Kirin Brewery, Tokyo, Japan) daily for 5 days. Shamoperated (sham) rats served as controls to exclude the possibility that the drugs themselves directly alter sympathetic reinnervation. Thus, rats were assigned to the following four groups: sham, sham with G-CSF treatment (sham/G), MI/C, and MI/G. The heart was excised on days 5 or 56 after MI as early and late remodeling of sympathetic innervation. The animal experiments were approved and conducted in accordance with local institutional guidelines for the care and use of laboratory animals in the Chi-Mei Medical Center (no. 95021301).
Echocardiography. To confirm that G-CSF administration is effective in improving of cardiac function and remodeling, transthoracic echocardiography was performed using a HP Sonos 5500 system equipped with a 15-6L probe (6 -15 MHz, SONOS 5500, Philips Medical System, Best, The Netherlands) in rats under anesthesia with ketamine (90 mg/kg ip) on days 0 and 56 as previously described (28) . M-mode tracing of the LV from the parasternal long-axis view was obtained to measure the LV end-diastolic diameter dimension (LVEDD) and LV end-systolic diameter dimension (LVESD), and fractional shortening (FS; in %) was calculated.
Hemodynamics and infarct size measurements. Hemodynamic parameters and infarct size were measured on day 56 after MI as previously described (28) . Using a 2-Fr micromanometer-tipped catheter (model SPR-407, Millar Instruments, Houston, TX) inserted through the right carotid artery, we measured LV systolic and diastolic pressure as the mean of measurements from five consecutive pressure cycles. The maximal rate of the LV pressure rise (ϩdP/dt) and decrease (ϪdP/dt) was measured. After the arterial pressure measurement, rats were intubated and artificially ventilated with humidified room air supplemented with oxygen for in vivo electrophysiological experiments. After completion of the electrophysiological tests, the hearts were immediately divided into the right and left atria, right ventricles, LVs, and scarred areas. Each tissue was then weighed individually. To evaluate the degree of pulmonary edema, lungs were also weighed. It has been shown that hypertrophy of the residual myocardium progresses after infarction only if the infarct size is Ͼ30% of the LV (34) . Thus, with respect to clinical importance, only rats with infarction Ͼ30% of the LV were selected for analysis.
In vivo electrophysiological experiments. To assess the potential arrhythmogenic risk of G-CSF administration, we performed in vivo programmed electric stimulation. Because the residual neural integrity at the infarct site is one of the determinants of the response to electrical induction of ventricular arrhythmias (19) , only rats with a transmural scar on day 56 after infarction were included. Body temperature was maintained at 37°C with a thermostatically controlled heating lamp. Programmed electrical stimulation was performed with electrodes sewn to the epicardial surface of the right ventricular outflow tract. Arrhythmias were induced with the Bloom stimulator. To induce ventricular arrhythmias, pacing was performed at a cycle length of 120 ms (S 1) for eight beats followed by one to three extrastimuli (S2, S3, and S4) at shorter coupling intervals. The end point of ventricular pacing was the induction of ventricular tachyarrhythmia. Ventricular tachyarrhythmias, including ventricular tachycardia and ventricular fibrillation, were considered nonsustained when they lasted Յ15 beats and sustained when they lasted Ͼ15 beats. An arrhythmia scoring system was modified as previously described (27) , so that 0 ϭ noninducible preparations, 1 ϭ nonsustained tachyarrhythmias induced with three extrastimuli, 2 ϭ sustained tachyarrhythmias induced with three extrastimuli, 3 ϭ nonsustained tachyarrhythmias induced with two extrastimuli, 4 ϭ sustained tachyarrhythmias induced with two extrastimuli, 5 ϭ nonsustained tachyarrhythmias induced with one extrastimulus, 6 ϭ sustained tachyarrhythmias induced with one extrastimulus, and 7 ϭ tachyarrhythmias induced during the eight paced beats. If the heart stopped before the pacing, the arrhythmia score assigned to that heart was 8. When multiple forms of arrhythmias occurred in one heart, the highest score was used. Experimental protocols were typically completed within 10 min.
Real-time RT-PCR of nestin and NGF mRNA. Real-time quantitative RT-PCR was performed from samples obtained from the border zone (0 -2 mm outside the infarct) with the TaqMan system (Prism 7700 Sequence Detection System, PE Biosystems) on day 5 for nestin and day 56 for NGF as previously described (28) . For nestin (GenBank Accession No. NM_012987), the primers were 5Ј-TTTGAGGACCTAGGGACTGAGGC-3Ј (sense) and 5Ј-CCA-GAAGGCTCAGCACTGTCCTG-3Ј (antisense). For NGF, the primers were 5Ј-TCCACCCACCCAGTCTTCCA-3Ј (sense) and 5Ј-GCCTTCCTGCTGAGCACACA-3Ј (antisense). For cyclophilin, the primers were 5Ј-ATGGTCAACCCCACCGTGTTCTTCG-3Ј (sense) and 5Ј-CGTGTGAAGTCACCACCCTGACACA-3Ј (antisense). Cyclophilin mRNA was chosen as the internal standard because it is expressed at a relatively constant level in virtually all tissues. For quantification, nestin and NGF expression were normalized to the expression of the housekeeping gene cyclophilin. Reaction conditions for 40 rounds of amplification were carried out.
Western blot analysis of nestin and NGF. Samples obtained from the border zone and remote zone (Ͼ2 mm outside the infarct) on day 5 for nestin analysis and day 56 for NGF analysis were homogenized with a kinametic Polytron blender. Homogenates were centrifuged at 10,000 g for 30 min to pellet the particulate fractions. Protein (20 g) was separated by 10% SDS-PAGE and electrotransferred onto a nitrocellulose membrane. The nitrocellulose membrane was then incubated with rabbit polyclonal anti-nestin antibody (clone rat-401, Chemicon) at 1:1,000 dilution and with rabbit polyclonal anti-NGF antibody (Chemicon) at 1:500 dilution for 2 h. Antigen-antibody complexes were detected with HRT substrate peroxide solution (Millipore, Billerica, MA). Films were volume integrated within the linear range of the exposure using a scanning densitometer. The relative abundance of nestin and NFG protein was obtained by normalizing the density of nestin and NFG protein against that of ␤-actin. Experiments were replicated three times, and results are expressed as mean values.
Immunohistochemical experiments of CD34, nestin, glial fibrillary acidic protein, tyrosine hydroxylase, growth-associated protein 43, and neurofilament. To investigate the spatial distribution and quantification of sympathetic nerve fibers, the analysis of immunohistochemical staining was performed on LV muscle from the border zone on days 5 and 56. Papillary muscles were excluded from the study because a variable sympathetic innervation has been reported (10) . Because nestin may be also expressed in non-neural stem cells (13) , glial fibrillary acidic protein was stained to confirm the nature of nestin ϩ neural stem cells. The coexpression of glial fibrillary acidic protein in nestin ϩ neural stem cells was recognized as a phenotype of neural progenitors (16) . Paraffin-embedded tissues were sectioned at a thickness of 5 m. Tissues were incubated with anti-CD34 (1:200, Santa Cruz Biotechnology, Santa Cruz, CA), anti-nestin (1:200, clone rat-401, Chemicon), anti-glial fibrillary acidic protein (1:500, Chemicon), anti-tyrosine hydroxylase (1:200, Chemicon), anti-growth-associated protein 43 (a marker of nerve sprouting, 1:400, Chemicon), and anti-neurofilament antibodies (a marker of sympathetic nerves, 1:1,000, Chemicon) in 0.5% BSA in PBS overnight at 37°C. Immunostaining was performed using a standard immunoperoxidase technique (N-Histofine Simple Stain MAX PO kit, Nichirei, Tokyo, Japan). Immunofluorescence was used for tissues stained with nestin and glial fibrillary acidic protein. Secondary antibodies were goat anti-mouse IgG conjugated to rhodamine (1:250 -1:500, Molecular Probes) and goat anti-rabbit IgG conjugated to FITC (1:500, Jackson Laboratories). Immunolabeled sections were examined through the use of confocal laser scanning microscopy (Nikon C1si, Tokyo, Japan) as previously described (29) . Isotype-identical directly conjugated antibodies served as negative controls.
The slides were coded so that the investigator was blinded to the identification of the rat sections. Slides were initially scanned at low power (ϫ100) to identify areas of intense staining. Nerve density was measured from areas of intense staining on the tracings by computerized planimetry (Image Pro Plus, Media Cybernetics, Silver Spring, MD) as previously described (29) . The density of nerve fibers was quantitatively measured from 10 randomly selected fields at a magnification of ϫ400 and expressed as the ratio of labeled nerve fiber area to total area (n ϭ 8 per group). Likewise, the colocalization of nestin with glial fibrillary acidic protein fluorescence was quantitatively analyzed. For a quantitative analysis, numbers of CD34 ϩ cells were counted in at least three randomly selected fields of view in each slide (n ϭ 8 per group) at a magnification of ϫ400 in the border zone.
Laboratory measurements. To confirm the effect of G-CSF, blood samples (0.2 ml) were taken from the tail vein on days 0, 5, 28, and 56 after saline or G-CSF treatment (n ϭ 8 per group). Blood cell counts were performed on a Coulter counter (T-660, Coulter Electronics, Hialeah, FL), and differential leukocyte counts were measured in a central laboratory by independent, experienced observers without knowledge of the group or sampling time.
Although cardiac reinnervation has been shown in immunohistochemical staining of tyrosine hydroxylase, growth-associated factor 43, and neurofilament, it did not imply that the nerves are functional. Thus, to examine the sympathetic nerve function after the administration of G-CSF, we measured LV norepinephrine levels from the border zone on day 56 after infarction. Myocardial tissue samples were minced and suspended in 0.4 N perchloric acid with 5 mmol/l reduced glutathione (pH 7.4) and homogenized with a Polytron homogenizer for 60 s in 10 volumes. Samples were immediately centrifuged at 3,000 g for 10 min, and the supernatant was stored at Ϫ70°C until further analysis. The supernatant protein concentration was determined using the BCA protein assay reagent kit (Pierce). Total norepinephrine levels were measured using a commercial ELISA kit (Noradrenalin ELISA, IBL Immuno-Biological Laboratories, Hamburg, Germany).
Statistical analysis. Results are presented as means Ϯ SD. Differences among the groups were tested using one-way ANOVA. Subsequently, analysis for significant differences between the two groups was performed with a multiple-comparison test (Scheffé's method). Electrophysiological data (scoring of programmed electrical stimulation-induced arrhythmias) were compared with a Kruskal-Wallis test followed by a Mann-Whitney test. The relationships between the nestin ϩ and glial fibrillary acidic protein ϩ area fraction (%) and tyrosine hydroxylase-positive area fraction (%) were analyzed by Spearman correlation and multiple linear regression. The significant level was set at P Ͻ 0.05.
RESULTS
We found no significant differences in mortality between the two infarcted groups throughout the study (4 of 15 infarcted rats in the MI/C group and 3 of 15 infarcted rats in the MI/G group). G-CSF had little effect on cardiac gross morphology in the sham rats (Table 1) . At 56 days after infarction, the infarcted area of the LV was very thin and was totally replaced by fully differentiated scar tissue. The weight of the LV inclusive of the septum remained essentially constant at 56 days between the infarcted groups. Infarct size did not differ between the infarcted groups.
Hemodynamics. On day 56 after infarction, G-CSF did not significantly affect systolic blood pressure in MI/G rats compared with MI/C rats (Table 1) . ϩdP/dt and ϪdP/dt were significantly improved in the MI/G group on day 56 compared with MI/C rats.
Peripheral blood cell counts. Neutrophil counts in peripheral blood are shown in Fig. 1 . The neutrophil counts showed a significant increase in the G-CSF-treated groups than that in the saline groups on day 5 and decreased thereafter. There was a similar increase in neutrophils between sham/G and MI/G rats. There were no significant changes in lymphocytes, red blood cells, or platelets throughout the experiment in the four groups (data not shown).
Echocardiography. As shown in Fig. 2 , echocardiography showed a significant decrease in LVEDD and significant increases in LV FS in MI/G rats compared with MI/C rats on day 56 after MI. These findings suggest improvements in LV remodeling and function by G-CSF treatment.
Immunohistochemical analyses. To show the extent of stem cell mobilization after G-CSF application, immunohistochemical analyses from the border zone on day 5 were performed. As shown in Fig. 3 , G-CSF promoted CD34
ϩ cell mobilization and homing to the myocardium after MI. G-CSF significantly increased the number of CD34 ϩ cells in MI/G rats on day 5 compared with MI/C rats [12 Ϯ 7 vs. 5 Ϯ 4 cells/high-power field (magnification: ϫ400), P Ͻ 0.05].
In the LV of sham rats, nestin-immunoreactive cells were not detected in the myocardium (data not shown). Nestin immunoreactivity was observed in the border zone on day 5 after MI, which was associated with fiber-like structures (Fig.  3) . The amount of neural stem cells coexpressing nestin ϩ and glial fibrillary acidic protein ϩ cells was significantly higher in MI/G rats than in MI/C rats. To further delineate the phenotype, the expression of the sympathetic neuronal protein tyrosine hydroxylase, growthassociated protein 43, and neurofilament was examined. On day 5, there were no significant quantitative differences in the area fractions of tyrosine hydroxylase ϩ nerve fibers between the infarcted groups (data not shown). On day 56, the tyrosine hydroxylase ϩ nerve area fraction was significantly larger in MI/C rats than in sham rats (Fig. 4) . Furthermore, MI/G rats showed significantly larger nerve area fractions in the border zone than MI/C rats (0.28 Ϯ 0.08% in MI/G rats vs. 0.17 Ϯ 0.05% in MI/C rats, P Ͻ 0.0001). Similar to the tyrosine hydroxylase results, the area fractions of growth-associated protein 43 ϩ and neurofilament ϩ nerve fibers were significantly increased in MI/G rats compared with MI/C rats (0.15 Ϯ 0.05% in MI/G rats vs. 0.09 Ϯ 0.03% in MI/C rats for growth-associated protein 43, P Ͻ 0.0001, and 0.18 Ϯ 0.04% in MI/G rats vs. 0.07 Ϯ 0.02% in MI/C for neurofilament, P Ͻ 0.0001). As shown in Fig. 5 , there was a significant correlation between the nestin ϩ and glial fibrillary acidic protein ϩ area fraction (in %) and tyrosine hydroxylase-positive area fraction (in %) in infarcted rats (P Ͻ 0.001). Figure 6 shows the serial changes in the myocardial protein expression of nestin. Western blot analysis showed that nestin expression levels were significantly upregulated (by 2.0-fold) in the border zone in MI/C rats compared with sham rats (P Ͻ 0.0001) on day 5. On day 5, compared with MI/C rats, nestin levels in MI/G rats were significantly higher in the border zone. On day 56, nestin protein levels returned to normal levels in the border and remote zones. Corresponding changes for nestin were obtained by immunofluorescent detection (data not shown).
Western blot analysis and real-time RT-PCR of nestin and NGF.
Western blot analysis showed that NGF levels were significantly upregulated (by 1.8-fold) in the border zone in MI/C rats compared with sham rats (P Ͻ 0.0001; Fig. 7 ) on day 56. Compared with MI/C rats, NGF levels in MI/G rats were significantly higher in the border zone.
PCR amplification of cDNA revealed that nestin mRNA levels showed 2.7-fold upregulation in the border zone in MI/C rats compared with sham rats (P Ͻ 0.0001; Fig. 8) . In MI/G rats, nestin mRNA levels were significantly increased compared with those in MI/C rats on day 5. The increased magnitude of nestin mRNA levels was similar to the protein level changes, implying that nestin production is a critical regulation step in nerve sprouting. Similar to the nestin mRNA change, NGF mRNA levels were significantly increased in MI/G rats compared with MI/C rats on day 56 after infarction (Fig. 8) .
Circulating and myocardial norepinephrine levels. Circulating plasma norepinephrine levels remained similar between the two infarcted groups (Table 1) . Although cardiac reinnervation has been shown in immnohistochemical staining of tyrosine hydroxylase, growth-associated protein 43, and neurofilament, it did not imply that the nerves are functional. Thus, to investigate cardiac sympathetic function, we determined ventricular norepinephrine levels. G-CSF administration did not affect the basal tissue norepinephrine concentrations in the sham group. LV norepinephrine levels were significantly upregulated (by 2.02-fold) in the border zone in MI/C rats compared with sham rats (2.33 Ϯ 0.20 vs. 1.37 Ϯ 0.35 g/g protein, P Ͻ 0.0001). Compared with MI/C rats, LV norepinephrine levels in MI/G rats were significantly higher in the border zone on day 56.
Electrophysiological stimulation. To further elucidate the physiological effect of the increase of sympathetic reinnervation, ventricular pacing was performed. A representative electrocardiogram record in a MI/C rat is shown in Fig. 9 . The arrhythmia scores in sham rats were very low (0.2 Ϯ 0.4). In contrast, ventricular tachyarrhythmias (consisting of ventricular tachycardia and ventricular fibrillation) were inducible by programmed stimulation in MI/C rats. The MI/G group showed a significant increase in the inducibility of ventricular tachyarrhythmias compared with the MI/C group on day 56.
DISCUSSION
The present study demonstrated that G-CSF recruited CD34 ϩ cells and nestin-expressing stem cells in the early stage of MI and increased NGF expression and sympathetic reinnervation in the late stage of MI. Although some improvement in ventricular function represented a positive outcome of G-CSF administration, this treatment has the potential downside of creating excessive sympathetic reinnervation that may predispose the heart to arrhythmias. These results were concordant with the effects of G-CSF, as documented structurally, by the increase in cardiac nerve sprouting, molecularly, by myocardial nestin and NGF protein expression and mRNA levels, biochemically, by tissue norepinephrine levels, and electrophysiologically, by aggravation of fatal ventricular tachyarrhythmias.
In contrast with previous studies with G-CSF, the present study demonstrates a side effect of G-CSF. The effect of G-CSF on worsening fatal arrhythmias was supported by the following lines of evidence: 1) there was a G-CSF effect on CD34 ϩ cells and nestin expression in the early stage of MI, 2) excessive sympathetic reinnervation was observed in the border zone in the late stage of MI (day 56) but not on day 5, and 3) the severity of pacing-induced fatal arrhythmias was associated with the degree of sympathetic reinnervation. Rats were divided into the following groups: sham-operated rats (sham group), sham rats treated with granulocyte-stimulating factor (G-CSF; sham/G group), MI rats treated with saline (MI/C group), and MI rats treated with G-CSF (MI/G group). The increase of neutrophil count was greater in G-CSF-treated groups than in saline-treated groups. Data are represented as means Ϯ SD; n ϭ 8 rats/group. *P Ͻ 0.05 vs. sham rats and MI/C rats at the same age.
Evidence of a G-CSF effect on CD34
ϩ cells and nestin expression in the early stage of MI. On day 5 after MI, in addition to an increase in the number of neutrophils, the most striking effect of peripheral administration of G-CSF on the myocardium was seen in the border zone, where G-CSF significantly increased the number of tissue-infiltrating CD34 ϩ cells in infarcted rats. G-CSF treatment promoted CD34 ϩ cell infiltration in the infarcted myocardium of MI rats but not in the myocardium of sham rats, despite a similar increase in the peripheral neutrophil count. Our finding was consistent with the findings of Abbott et al. (1), who showed that stem cell mobilization alone did not lead to significant engraftment of circulating cells in tissues expressing inefficiency of chemoattractant factors. Under the influence of chemoattractants, such as stromal cell-derived factor 1, that are produced in response to injury, G-CSF upregulated CXCR4 expression on CD34 ϩ cells, receptors of stromal cell-derived factor 1, and promoted effective recruitment of circulating CD34 ϩ cells attached to the myocardium (1).
Since we found increased mobilization and homing capacity of CD34 ϩ progenitor cells, we addressed the question of if these cells may have induced nerve remodeling in the ischemic myocardium. The enriched CD34 ϩ progenitor cells were paralleled by a high number of nestin ϩ -glial fibrillary acidic protein ϩ cells in the border zone. The observation was consistent with the findings of Shyu et al. (37) , who showed that implanted CD34 ϩ stem cells can differentiate into nestin ϩ neurons and glial fibrillary acidic protein ϩ glial cells. In infarcted rats, G-CSF plays a pivotal role in increasing the nestin expression level, which was accompanied by the induction of nestin mRNA in the border zone. Nestin is known to be involved in enhancing neuronal sprouting, synaptogenesis, and neurite outgrowth, which are indispensable for neurite extension after MI. Our results were consistent with the notion that denervation resulted in an upregulation of nestin in Schwann cells of axotomized nerves at the acute phase but diminished nestin immunoreactivity on day 56, when the muscle is reinnervating (15) .
Excessive sympathetic reinnervation was observed in the border zone in the late stage of MI (day 56) but not at day 5.
The finding was compatible with the notion that an infarcted myocardium causes a disappearance of sympathetic innervation, which is followed by a phase of excessive sympathetic reinnervation (19) . Transcription and translation levels of NGF were significantly increased after the administration of G-CSF in infarcted rats. Our results were consistent with the findings of Drapeau et al. (12), who showed that neural stem cells were initially recruited to the infarct region of the damaged rat heart and consequently contribute to sympathetic innervation, probably through enhancing NGF expression. As the morphological features of sympathetic reinnervation appeared to be increased at 56 days after infarction, sympathetic nerve function, as assessed by the norepinephrine content of the myocardium, showed a significant increase. Thus, the structural features of sympathetic ingrowth are established not only at anatomic impact but also at functional features of this sprouting phenomenon. G-CSF, a neuronal ligand, counteracts programmed cell death and drives neurogenesis because it acts on neurons that express G-CSF receptors (35) . However, according to our results, preventing neuron apoptosis is not a mechanism by which G-CSF enhanced sympathetic reinnervation because tyrosine hydroxylase-immunoreactive fibers were similarly reduced at 5 days in infarcted rats treated with or without G-CSF.
The severity of pacing-induced fatal arrhythmias was associated with the degree of sympathetic reinnervation. Although a previous study (33) has shown that stem cell administration induced increased sympathetic nerve density, this study did not provide evidence that the nerve sprouts are destined to become hyperfunctional and to induce fatal arrhythmias. Our findings are further supported by Cao et al. (6) , who showed that increased postinjury sympathetic nerve density may be responsible for the occurrence of ventricular arrhythmia and sudden cardiac death.
Although the beneficial effect of G-CSF on post-MI LV remodeling and function has been observed in several studies (18, 31, 32) , controversy still exists. Previous studies (31, 32) using G-CSF alone or in combination with stem cell factor either before or immediately after MI induction in mice have reported improved function, attributing these effects to new vessel formation and decreased apoptosis of cardiomyocytes. On the other hand, Deten et al. (11) showed no functional benefits. Deten et al. (11) reported that even though c-Kit ϩ and CD45
Ϫ stem cell mobilization happens, it is not enough to bring any beneficial effect for the infarcted heart. In the present study, the administration of G-CSF showed subtle but significant improvements in physiological parameters, including hemodynamics and echocardiographic data. This discrepancy could be due to differences in protocols, species, the time point of treatment initiation, and periods of treatment. Indeed, homing of stem cells or even the access of G-CSF itself to the infarcted region of the myocardium is impaired when the coronary artery is permanently occluded and G-CSF is administered after coronary ligation. Other mechanisms. Although the present study suggests that the mechanisms of enhanced G-CSF-induced sympathetic reinnervation and proarrhythmia are related to increased nestin expression, other potential mechanisms need to be studied, such as paracrine/autocrine effects and cardiac fibrosis. First, G-CSF may directly activate VEGF signals. VEGF has been shown to stimulate neurite outgrowth in retinal ganglion cell cultures (3) and cerebral cortical neurons (23) via VEGF receptor 2. Second, G-CSF exacerbated cardiac fibrosis (8) , thereby inducing the risk of isolated regional slowing of conduction and reentrant arrhythmias.
Study limitations. There are some limitations to the present study that have to be acknowledged. First, we used the small size of the rat heart to our advantage to quantify the changes of nerve sprouting after MI. Although rats offer an incredibly valuable tool for the study of post-MI remodeling, it is essential to be aware of differences that exist between animal models and human disease. We must bear in mind that the results obtained in the experimental animals may not translate directly to humans. The drug effect of permanent coronary occlusion in the rat model and late patency of the infarcted-related artery in most clinical settings on the development of sympathetic reinnervation may be different. Furthermore, coronary artery ligation in the rat usually results in a large transmural infarct size (average: 40%), which contrasts to MI in humans. Second, recent technological developments in echocardiography have facilitated the analysis of ventricular remodeling and heart function after the induction of MI in small laboratory animals, but there are limitations compared with human echocardiography. Mainly, LV dimensions were estimated either from onedimensional M-mode tracings (38) , area measurements in parasternal views (9) , or volume calculations from single cross sections (14) . These methods have been validated in humans, but it is generally recognized that the accuracy of the prolateellipse, area-length, and truncated ellipsoid methods is limited to normally shaped and sized ventricles, whereas the biplane method of disks is accurate in abnormally shaped ventricles (26) . Due to the small heart size, the high heart rate, and technical limitations, delineation of endocardial borders in rats is conventionally not possible in apical views. Indeed, the M-mode used in this study is the most common measurement of LV remodeling and function after infarction in rats. Third, the source and phenotype of the progenitor cell that gave rise to nestin-expressing neural stem cells in the border zone remain presently undefined. The normal heart may contain a reservoir of resident cardiac progenitor cells (42) that, after damage, differentiate to a neural stem cell phenotype. Either residing cardiac stem cells or bone marrow stem cells might migrate to the infarct site and differentiate to neural progenitor Fig. 9 . Top: representative sustained ventricular arrhythmias induced by ventricular pacing in a sham rat. After eight basic stimuli (S) at a cycle length of 120 ms, sustained ventricular tachyarrhythmias were observed (score: 7). Bottom: inducibility quotient of ventricular arrhythmias by programmed electrical stimulation at 56 days after MI in an in vivo model. Results are means Ϯ SD; n ϭ 9 rats/group. *P Ͻ 0.05 compared with sham and sham/G rats; †P Ͻ 0.05 compared with MI/C rats. Fig. 8 . LV nestin mRNA levels in the border zone on day 5 after MI and NGF mRNA levels in the border zone on day 56 after MI. Each mRNA was corrected for the mRNA level of cyclophilin. Cyclophilin mRNA levels served as the internal standard. All samples were run in triplicate. Data are represented as means Ϯ SD; n ϭ 8 rats/group. *P Ͻ 0.05 compared with sham and sham/G rats; †P Ͻ 0.05 compared with MI/C rats. cells (17) . Finally, it is unknown whether nestin-expressing cells are necessarily destined to become functional neurons or simply exhibit ectopic expression of such markers as part of an injury response. Nestin expression was also detected in pancreatic stem cells, endothelial cells during active angiogenesis, and myocardium-derived c-Kit ϩ progenitor cells (22) . Whether they would eventually express mature neuronal markers, such as neuronal nuclear antigen-positive and microtubule-associated protein 2, remains to be determined. The enhanced expression of tyrosine hydroxylase and tissue norepinephrine levels in the myocardium could reflect the increased production of norepinephrine from nerve sprouting of mature sympathetic neurons.
Conclusions. These data show that G-CSF was associated with mobilization of CD34 ϩ cells and increases of nestin and NGF expression and played an important role in the sympathetic reinnervation within the infarcted myocardium. These effects are functionally and structurally important because they are linked to increased severity of fatal arrhythmias. Further studies, including a longer-term observation, are needed to more conclusively address the effectiveness and safety of G-CSF therapy.
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